PRISM

Biomarker

1 paper1 finding

  • Humans1

Associations

1

High-risk clonal haematopoiesis or future myeloid neoplasia

upin humans1

1 study
  1. PRISM predicts high-risk clonal haematopoiesis or future myeloid neoplasia in humans (AUC 0.89 (95% CI 0.85–0.93)).

    “Validation of PRISM revealed an area under the curve of 0.89 (95% CI 0.85-0.93) in the UK Biobank test cohort”

    HumansUK Biobank internal test cohortn = 92,316

    Blood counts help flag high-risk blood cancer precursors

    EClinicalMedicine22 Sep 2026

More on High-risk clonal haematopoiesis or future myeloid neoplasia

Latest

Nov 2025: 0Dec 2025: 5Jan 2026: 3Feb 2026: 3Mar 2026: 1Apr 2026: 0May 2026: 0Jun 2026: 1Jul 2026: 1Aug 2026: 3Sep 2026: 5Oct 2026: 123 in 12 months
EClinicalMedicine

Blood counts help flag high-risk blood cancer precursors

The model categorised all high-risk cases as positive and pre-classified 40% of low-risk cases and 55% of negative cases as negative.The model categorised all high-risk cases as positive and pre-classified 40% of low-risk cases and 55% of negative cases as negative.

Cohort study of 461,576 peopleBiomarkers
Journal of the American Heart Association

Sleep apnoea with impaired lung function linked to heart risk

Over a median 11.45 years, major heart and brain blood-vessel events affected 49.40% with both conditions, versus 17.00% without sleep apnoea and with normal lung…Over a median 11.45 years, major heart and brain blood-vessel events affected 49.40% with both conditions, versus 17.00% without sleep apnoea and with normal lung function.

Cohort study in peopleLung